Personal Care Stocks Q4 Results: Benchmarking Herbalife (NYSE:HLF)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the personal care stocks, including Herbalife (NYSE:HLF) and its peers.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the personal care stocks, including Herbalife (NYSE:HLF) and its peers.
AT&T has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 25% and now trades at $26.99. This run-up might have investors contemplating their next move.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Acushnet (NYSE:GOLF) and the best and worst performers in the leisure products industry.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the semiconductors stocks, including Western Digital (NASDAQ:WDC) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how it distribution & solutions stocks fared in Q4, starting with Insight Enterprises (NASDAQ:NSIT).
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the government & technical consulting industry, including Amentum (NYSE:AMTM) and its peers.
Astec has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 13% and now trades at $35.82. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at L.B. Foster (NASDAQ:FSTR) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how online marketplace stocks fared in Q4, starting with Etsy (NASDAQ:ETSY).
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna (NASDAQ:MRNA) and the best and worst performers in the therapeutics industry.